Nuvectis Pharma Inc.

AI Score

0

Unlock

6.74
0.03 (0.45%)
At close: Feb 28, 2025, 3:59 PM
6.69
-0.74%
After-hours: Feb 28, 2025, 04:00 PM EST

Nuvectis Pharma Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue n/a n/a 149K n/a n/a
Cost of Revenue n/a 22.9M 19.23M 12.89M n/a
Gross Profit n/a -22.9M -19.09M -12.89M n/a
Operating Income n/a -22.9M -19.23M -12.89M -10K
Interest Income n/a 637K 149K 4K n/a
Pretax Income -19M -22.26M -19.09M -12.89M -10K
Net Income -19M -22.26M -18.79M -12.89M -10K
Selling & General & Admin 6.93M 7.52M 6.01M 3.35M 10K
Research & Development 12.92M 15.38M 13.23M 9.54M n/a
Other Expenses n/a n/a n/a n/a n/a
Operating Expenses 19.85M 22.9M 19.23M 12.89M 10K
Interest Expense n/a n/a 149K n/a n/a
Selling & Marketing Expenses n/a 14K n/a n/a 9.98K
Cost & Expenses n/a 22.9M 19.23M 12.89M 10K
Income Tax -19M n/a -298K -4K -24
Shares Outstanding (Basic) 17.11M 15.56M 12.66M 12.72M 12.72M
Shares Outstanding (Diluted) 17.11M 15.56M 12.66M 12.72M 12.72M
EPS (Basic) -1.11 -1.43 -1.48 -1.01 -0.00
EPS (Diluted) -1.11 -1.43 -1.48 -1.01 -0.00
EBITDA n/a -22.9M -19.23M -12.89M n/a
Depreciation & Amortization n/a -1M -1.2M -7.1M 24K